Atomoxetine hydrochloride is marketed under the brand name Strattera [1].
What is Strattera used for?
Strattera is a medication used to treat attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults [2]. It is a non-stimulant medication, meaning it does not have the same potential for abuse as stimulant ADHD drugs [3].
How does Strattera work?
Strattera's active ingredient, atomoxetine hydrochloride, is a selective norepinephrine reuptake inhibitor [4]. It works by increasing the levels of norepinephrine, a neurotransmitter, in the brain [4]. Norepinephrine plays a role in attention, impulse control, and hyperactivity [4].
When did Strattera become available?
Strattera was first approved by the U.S. Food and Drug Administration (FDA) in 2002 [5].
When does the patent for Strattera expire?
Patent expiration dates can be complex due to multiple patents covering different aspects of a drug, including formulations and manufacturing processes. Information on specific patent expirations for Strattera can be found through resources like DrugPatentWatch.com [6].
What are the potential side effects of Strattera?
Common side effects of Strattera can include upset stomach, nausea, vomiting, decreased appetite, weight loss, dizziness, fatigue, insomnia, and increased blood pressure or heart rate [7]. Less common but more serious side effects may include liver problems, psychiatric side effects (such as aggression or suicidal thoughts), and urinary retention [7].
Are there alternatives to Strattera for ADHD treatment?
Yes, there are other treatment options for ADHD. These include stimulant medications, such as Adderall and Ritalin, and other non-stimulant medications like guanfacine and clonidine [8]. Behavioral therapy is also a common and effective treatment approach, often used in conjunction with medication [8].
Who manufactures Strattera?
Strattera is manufactured by Eli Lilly and Company [1].
Sources:
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&Appl_No=021123
[2] https://www.webmd.com/drugs/2/drug-5790/strattera-oral/details
[3] https://www.drugbank.ca/drugs/DB00379
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920931/
[5] https://www.fda.gov/news-events/press-announcements/drug-approvals-and-certifications-archive-2002
[6] https://drugpatentwatch.com/
[7] https://www.mayoclinic.org/drugs-supplements/atomoxetine-oral-route/side-effects/drg-20061216
[8] https://www.cdc.gov/ncbddd/adhd/treatment.html